Differential requirements for CD28 and CD40 ligand in the induction of experimental autoimmune myasthenia gravis

European Journal of Immunology

Volumn 28, Issue 11, 1998, Pages 3587-3593

  Shi, Fu Dong ^a,b   He, Bing ^a   Li, Hulun ^a   Matusevicius, Darius ^a   Link, Hans ^a   Ljunggren, Hans Gustaf ^b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

CD28; CD40 ligand; Cytokine; Experimental autoimmune myasthenia gravis; IgG isotype

Indexed keywords

B7 ANTIGEN; CD28 ANTIGEN; CD40 ANTIGEN; CHOLINERGIC RECEPTOR; GLYCOPROTEIN GP 39; IMMUNOGLOBULIN G1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNE DISEASE; B LYMPHOCYTE; CONTROLLED STUDY; FEMALE; HELPER CELL; MOUSE; MYASTHENIA GRAVIS; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, CD28; CD40 LIGAND; IMMUNOGLOBULIN G; INTERFERON TYPE II; LYMPHOCYTE ACTIVATION; MEMBRANE GLYCOPROTEINS; MICE; MOLECULAR SEQUENCE DATA; MYASTHENIA GRAVIS; RECEPTORS, CHOLINERGIC;

EID: 0031770186     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-4141(199811)28:11<3587::AID-IMMU3587>3.0.CO;2-Y     Document Type: Article

References (29)

1. Sperling, A. I. and Bluestone, J. A., The complexities of T-cell co-stimulation: CD28 and beyond, Immunol. Rev. 1996. 153: 155-182.
2. Grewal, I. S. and Flavell, R. A., The role of CD40 ligand in costimulation and T-cell activation, Immunol. Rev. 1996. 153: 85-106.
3. Lenschow, D. J., Herold, K. C., Rhee, L., Patel, B., Koons, A., Qin, H. Y., Fuchs, E., Singh, B., Thompson, C. B. and Bluestone, J. A., CD28/B7 regulation of Th1 and Th2 subsets in the development of autoimmune diabetes. Immunity 1996. 5: 285-293.
4. Kuchroo, V. K., Das, M. P., Brown, J. A., Ranger, A. M., Zamvil, S. S., Sobel, R. A., Weiner, H. L., Nabavi, N. and Glimcher, L. H., B7-1 and B7-2 costimulatory molecules activate differentially the Th1-Th2 development pathways: application to autoimmune disease therapy. Cell 1995. 80: 707-718.
5. Grewal, I. S., Foellmer, H. G., Grewal, K. D., Xu, J., Hardardottir, F., Baron, J. L., Janeway Jr., C. A. and Flavell, R. A., Requirement for CD40 ligand in costimulation induction, T cell activation, and experimental allergic encephalomyelitis. Science 1996. 273: 1864-1867.
6. Balasa, B., Krahl, T., Palstone, G., Lee, J., Tisch, R., McDevitt, H. O. and Sarvetnick, N., CD40 ligand-CD40 interactions are necessary for the initiation of insulitis and diabetes in nonobese diabetic mice. J. Immunol. 1997. 159: 4620-4627.
7. Drachman, D., Myasthenia gravis. N. Engl. J. Med. 1994. 330: 1797-1810.
8. Berman, P. W. and Patrick, J., Experimental myasthenia gravis murine system. J. Exp. Med. 1980. 151: 204-223.
9. Shenoy, M., Oshima, M., Atassi, M. Z. and Christadoss, P., Suppression of experimental autoimmune myasthenia gravis by epitope-specific neonatal tolerance to synthetic region of α146-162 of acetylcholine receptor. Clin, Immunol. Immunopathol. 1993. 66: 230-238.
10. Renshaw, B. R., Fansbow III, W. C., Armitage, R. J., Camphell, K. A., Liggitt, D., Wright, B., Davison, B. L. and Maliszewski, C. R., Humoral immune responses in CD40 ligand deficient mice. J. Exp. Med. 1994. 180: 1889-1900.
11. Grewal, I. S., Xu, J. and Flavell, R. A., Impairment of antigen-specific T-cell priming in mice lacking CD40 ligand. Nature 1995. 378: 617-620.
12. Shahinian, A., Pfeffer, K., Lee, K. P., Kundig, T. M., Kishihara, K., Wakeham, A., Kawai, K., Ohashi, P. S. and Mak, T. W., Differential T cell costimulatory requirements in CD28-deficient mice. Science 1993. 261: 609-612.
13. Li, H., Shi, F. D., He, B., Bakheit, M., Wahren, B., Berglöf, A., Sandstedt, K. and Link, H., Experimental autoimmune myasthenia gravis induction in B cell deficient mice. Int. Immunol. 1998. 10: 1359-1365.
14. Sperling, A. I., Green, J. M., Mosley, R. L., Smith, P. L., Bluestone, J. A. and Thompson, C. B., CD43 is a murine T cell costimulatory receptor that functions independently of CD28. J. Exp. Med. 1995. 182: 139-146.
15. Schwartz, R. H., Costimulation of T lymphocytes: role of CD28, CTLA-4 and B7 in interleukin-2 production and immunotherapy. Cell 1992. 71: 1065-1068.
16. Mosmann, T. R. and Sad, S., The expanding universe of T cell subsets: Th1, Th2 and more, Immunol. Today 1996. 17: 138-146.
17. Seder, R. A., Germain, R. N., Linsley, P. S. and Paul, W. E., CD28-mediated costimulation of interleukin 2 (IL-2) production plays a critical role in T cell priming for IL-4 and Interferon gamma production. J. Exp. Med. 1994. 179: 299-304.
18. Zhang, G. X., Xiao, B. G., Bakhiet, M., van der Meide, P. H., Wigzell, H., Link, H. and Olsson, T., Both CD4+ and CD8+ T cells are essential to induce experimental autoimmune myasthenia gravis. J. Exp. Med. 1996. 184: 349-356.
19. Wu, B., Deng, C., Goluszko, E. and Christadoss, P., Tolerance to a dominant epitope in the acetylcholine receptor molecule induces epitope spread and suppresses murine myasthenia gravis. J. Immunol. 1997. 159: 3016-3023.
20. Balasa, B., Deng, C., Lee, J., Bradley, L. M., Dalton, D. K., Christadoss, P. and Sarvetnick, N., Interferon γ (IFN-γ) is necessary for the genesis of acetylcholine receptor-induced clinical experimental autoimmune myasthenia gravis in mice. J. Exp. Med. 1997. 186: 385-391.
21. Teresa, M. F., Laman, J. D., Ledbetter, J. A., Aruffo, A., Claassen, E. and Noelle, R. J., Gp39-CD40 interactions are essential for germinal center formation and development of B cell memory. J. Exp. Med. 1994. 180: 157-163.
22. Ferguson, S. E., Man, S., Kelsoe, G. and Thompson, C. B., CD28 is required for germinal center formation. J. Immunol. 1996. 156: 4576-4581.
23. Ma, J., Xu, J., Madaio, M. P., Peng, Q., Zhang, J., Grewal, I. S., Flavell, R. A. and Craft, J., Autoimmune lpr/ lpr mice deficient in CD40 ligand: spontaneous Ig class switching with dichotomy of autoantibody responses. J. Immunol. 1996. 157: 417-426.
24. Shi, F. D., Bai, X., Li, H., Huang, Y., van der Meide, P. H. and Link, H., Nasal tolerance in experimental autoimmune myasthenia gravis (EAMG): induction of protective tolerance in primed animals. Clin. Exp. Immunol. 1998. 111: 506-528.
25. Maliszewski, C. R., Grabstein, K., Fanslow, W. C., Armitage, R., Spriggs, M. K. and Sato, T. A., Recombinant CD40 ligand stimulation of murine B cell growth and differentiation: cooperative effects of cytokines. Eur. J. Immunol. 1993. 23: 1044-1049.
26. Armitage, R. J., Macduff, B. M., Spriggs, M. K. and Fanslow, W. C., Human B cell proliferation and Ig secretion induced by recombinant CD40 ligand are modulated by soluble cytokines. J. Immunol. 1993. 150: 3671-3680.
27. Xu, J., Foy, T. M., Laman, J. D., Elliott, E. A., Dunn, J. J., Waldschmidt, T. J., Elsemore, J., Noelle, R. J. and Flavell, R. A., Mice deficient for CD40 ligand. Immunity 1994. 1: 423-431.
28. Lindstrom, J., Einarson, B. and Tzartos, S., Production and assay of antibodies to acetylcholine receptors. Methods Enzymol. 1981. 74: 432-460.
29. Deibler, G. E., Martenson, R. E. and Kies, M. V., Large scale preparation of myelin basic protein from central nervous tissue of several mammalian species. Prep. Biochem. 1972. 2: 139-164.